Literature DB >> 16139180

Complex regional pain syndrome type-I after rubella vaccine.

Hakan Genc1, Aynur Karagoz, Meryem Saracoglu, Ebru Sert, Hatice Rana Erdem.   

Abstract

Complex regional pain syndrome type I (CRPS-I) is a complex disorder characterised by pain, autonomic dysfunction, and decreased range of motion. The syndrome was believed as a well-recognized disorder in adults but, less commonly recognized in children. CRPS-I after vaccination has been rarely reported. We reported an 11-year-old young girl with CRPS-I due to rubella vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16139180     DOI: 10.1016/j.ejpain.2004.11.003

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  5 in total

1.  [Please don't hurt me!: a plea against invasive procedures in children and adolescents with complex regional pain syndrome (CRPS)].

Authors:  B Zernikow; M Dobe; G Hirschfeld; M Blankenburg; M Reuther; C Maier
Journal:  Schmerz       Date:  2012-08       Impact factor: 1.107

Review 2.  Neuropathic pain in children: Special considerations.

Authors:  Gary A Walco; Robert H Dworkin; Elliot J Krane; Alyssa A LeBel; Rolf-Detlef Treede
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

3.  Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data.

Authors:  Nadja A Vielot; Sylvia Becker-Dreps
Journal:  Expert Opin Drug Saf       Date:  2019-11-08       Impact factor: 4.250

4.  Complex Regional Pain Syndrome Post COVID-19 Vaccine Shot: An Autobiographical Case Report.

Authors:  Praveena Raman
Journal:  Cureus       Date:  2021-12-08

5.  Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.

Authors:  Frank Huygen; Kristin Verschueren; Candida McCabe; Jens-Ulrich Stegmann; Julia Zima; Olivia Mahaux; Lionel Van Holle; Maria-Genalin Angelo
Journal:  EBioMedicine       Date:  2015-07-06       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.